The FDA has cleared Cerner to market its FetaLink+ fetal monitoring system. The technology is designed to allow clinicians to use their iPads or iPhones to access fetal and maternal data in near-real time and make informed medical decisions.
Mobile fetal monitoring device from Cerner wins FDA nod
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|